Analyst Ratings for Procept BioRobotics Corp (PRCT)
PRCT Rating Summary
PRCT Price Target Summary
- Highest: $55.00 (Guggenheim)
- Lowest: $37.00 (Goldman Sachs)
- Average: $47.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$47.50 (+13%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 87%
Avg. $ Target:
$47.50 (+13%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/15/2022 | KeyBanc | Matthew Mishan | New Coverage | Overweight (N/A) |
47.00 (N/A) |
32.11 (42.04) |
30.92% | Details |
| 7/12/2022 | Nephron | Chris Pasquale | New Coverage | Buy (N/A) |
50.00 (N/A) |
30.97 (42.04) |
35.74% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
